# 5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes

> **NCT02376920** · — · COMPLETED · sponsor: **Castle Biosciences Incorporated** · enrollment: 93 (actual)

## Conditions studied

- Uveal Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02376920
- **Lead sponsor:** Castle Biosciences Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376920, "5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02376920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*